This may counteract the neurovascular dysfunction caused by chronic overnutrition
Some patients maintain their results with lifestyle changes alone
doi: 10.1210/jcem-41-2-260 120 ChangAMJakobsenGSturisJSmithMJBloemCJAnBet al
Compounded versions may include inactive ingredients or vary in potency from batch to batch, which can impact how well the medication works or how safe it is
Activation of GLP-1 receptor delays the rate at which the stomach empties, leading to increased satiety and feeling of fullness
Metabolism & Elimination GLP2 undergoes metabolism through pathways typical of peptide therapeutics: Plasma half-life of approximately 5 days in humans, enabling once-weekly administration Primary metabolic pathways include proteolytic cleavage of the peptide backbone, beta-oxidation of the C20 fatty diacid moiety, and amide hydrolysis Not metabolized via cytochrome P450 enzymes, sulfation, or glucuronidation pathways Low potential for drug-drug interactions mediated through hepatic metabolism or transporter systems The extended half-life represents a key pharmacokinetic advantage, with steady-state accumulation of approximately 1.7-fold enabling consistent therapeutic exposure throughout the dosing interval
